仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Flanvotumab （IMC-20D7S） is a human monoclonal antibody targeting to tyrosinase-related protein （TYRP1）, specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity （ADCC）. Flanvotumab has potent anti-tumor activity and good tolerance